261 related articles for article (PubMed ID: 7214335)
21. Reduction of cisplatin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds.
Vermeulen NP; Baldew GS; Los G; McVie JG; De Goeij JJ
Drug Metab Dispos; 1993; 21(1):30-6. PubMed ID: 8095223
[TBL] [Abstract][Full Text] [Related]
22. Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice.
Yan L; Yee JA; Li D; McGuire MH; Graef GL
Anticancer Res; 1999; 19(2A):1337-42. PubMed ID: 10368696
[TBL] [Abstract][Full Text] [Related]
23. Selenocystine is not a cystine antimetabolite in L1210 cells.
Fisher JM; Rabinovitz M
Cancer Lett; 1985 Aug; 28(1):43-6. PubMed ID: 4027955
[TBL] [Abstract][Full Text] [Related]
24. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
25. Antitumoral activity of dipyrido [4,3-b] [3,4-f] indoles on L 1210 leukemia.
Lidereau R; Chermann JC; Gruest J; Montagnier L; Ducrocq C; Rivalle C; Bisagni E
Bull Cancer; 1980; 67(1):1-8. PubMed ID: 7362880
[TBL] [Abstract][Full Text] [Related]
26. Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture.
Hoefig CS; Renko K; Köhrle J; Birringer M; Schomburg L
J Nutr Biochem; 2011 Oct; 22(10):945-55. PubMed ID: 21190829
[TBL] [Abstract][Full Text] [Related]
27. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
28. Schedule-dependent synergism of methotrexate and vincristine against murine L1210 leukemia.
Chello PL; Sirotnak FM; Dorick DM; Moccio DM
Cancer Treat Rep; 1979; 63(11-12):1889-94. PubMed ID: 526921
[TBL] [Abstract][Full Text] [Related]
29. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa.
Gehrisch A; Dörr W
Strahlenther Onkol; 2007 Jan; 183(1):36-42. PubMed ID: 17225944
[TBL] [Abstract][Full Text] [Related]
30. Generation of reactive oxygen species from the reaction of selenium compounds with thiols and mammary tumor cells.
Yan L; Spallholz JE
Biochem Pharmacol; 1993 Jan; 45(2):429-37. PubMed ID: 8382065
[TBL] [Abstract][Full Text] [Related]
31. Selenium protection against mercury-induced apoptosis and growth inhibition in cultured K-562 cells.
Frisk P; Wester K; Yaqob A; Lindh U
Biol Trace Elem Res; 2003 May; 92(2):105-14. PubMed ID: 12746570
[TBL] [Abstract][Full Text] [Related]
32. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
Kim K; Blechman WJ; Riddle VG; Pardee AB
Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
[TBL] [Abstract][Full Text] [Related]
33. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
Zaharko DS; Ramonas LM
J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
[TBL] [Abstract][Full Text] [Related]
34. Effects of chemical form of selenium on plasma biomarkers in a high-dose human supplementation trial.
Burk RF; Norsworthy BK; Hill KE; Motley AK; Byrne DW
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):804-10. PubMed ID: 16614127
[TBL] [Abstract][Full Text] [Related]
35. [Effects of selenium polysaccharide and sodium selenite on blood selenium concentration and liver cytochrome P450 monooxygenase system in rat].
Cheng J; Hai T; Wu H; Song R
Wei Sheng Yan Jiu; 1998 Jan; 27(1):46-9. PubMed ID: 10682638
[TBL] [Abstract][Full Text] [Related]
36. Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice.
Müller AS; Most E; Pallauf J
J Anim Physiol Anim Nutr (Berl); 2005; 89(3-6):94-104. PubMed ID: 15787978
[TBL] [Abstract][Full Text] [Related]
37. Acute toxicity of sodium selenite and selenomethionine in mice after ICV or IV administration.
Ammar EM; Couri D
Neurotoxicology; 1981 Oct; 2(2):383-6. PubMed ID: 7198759
[TBL] [Abstract][Full Text] [Related]
38. NTP Toxicology and Carcinogenesis Studies of Sodium Fluoride (CAS No. 7681-49-4)in F344/N Rats and B6C3F1 Mice (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1990 Dec; 393():1-448. PubMed ID: 12637966
[TBL] [Abstract][Full Text] [Related]
39. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of selenazolidine prodrugs of selenocysteine: toxicity, selenium levels, and glutathione peroxidase induction in A/J mice.
Li L; Xie Y; El-Sayed WM; Szakacs JG; Roberts JC
Life Sci; 2004 Jun; 75(4):447-59. PubMed ID: 15147831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
